APA citiranje

Benson, D. M., Bakan, C. E., Zhang, S., Collins, S. M., Liang, J., Srivastava, S., . . . Farag, S. S. (2011). IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect. American Society of Hematology.

Citação norma Chicago

Benson, Don M., et al. IPH2101, a Novel Anti-inhibitory KIR Antibody, and Lenalidomide Combine to Enhance the Natural Killer Cell Versus Multiple Myeloma Effect. American Society of Hematology, 2011.

MLA citiranje

Benson, Don M., et al. IPH2101, a Novel Anti-inhibitory KIR Antibody, and Lenalidomide Combine to Enhance the Natural Killer Cell Versus Multiple Myeloma Effect. American Society of Hematology, 2011.